[1] da Costa TA, Silva MJB, Alves PM, et al. Inflammation biomarkers of advanced disease in nongingival tissues of chronic periodontitis patients[J]. Mediators Inflamm, 2015, 2015: 983782. [2] Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis[J]. Lancet, 2016, 388(10055): 2023-2038. [3] Mobini M, Maboudi A, Ali MR.Periodontitis in rheumatoid arthritis patients, abundance and association with disease activity[J]. Med J Islam Repub Iran, 2017, 31:44. [4] Kim JH, Choi IA, Lee JY, et al.Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults[J]. J Periodontal Implant Sci, 2018, 48(6): 347-359. [5] Rodríguez-Lozano B, González-Febles J, Garnier-Rodríguez JL, et al.Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case-control study[J]. Arthritis Res Ther, 2019, 21(1): 27. [6] Kaneko C, Kobayashi T, Ito S, et al.Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: a pilot case-control study[J]. PLoS One, 2018,13(2): e192365. [7] Papapanou PN, Sanz M, Buduneli N, et al.Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions[J]. J Clin Periodontol, 2018, 45(Suppl 20): S162-S170. [8] Aletaha D, Neogi T, Silman AJ, et al.2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62(9): 2569-2581. [9] de Oliveira FR, de Brito SR, Magno MB, et al. Does periodontitis represent a risk factor for rheumatoid arthritis? a systematic review and meta-analysis [J]. Ther Adv Musculoskelet Dis, 2019, 11: 1759720X19858514. [10] Äyräväinen L, Leirisalo-Repo M, Kuuliala A, et al.Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population[J]. BMJ Open, 2017, 7(1): e11916. [11] Naruishi K, Nagata T.Biological effects of interleukin-6 on gingival fibroblasts: cytokine regulation in periodontitis[J]. J Cell Physiol, 2018, 233(9): 6393-6400. [12] Balaji A, Chandrasekaran SC, Subramanium D, et al.Salivary Interleukin-6-A pioneering marker for correlating diabetes and chronic periodontitis: a comparative study[J]. Indian J Dent Res, 2017, 28(2): 133-137. [13] Stadler AF, Angst PD, Arce RM, et al.Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis[J]. J Clin Periodontol, 2016,43(9): 727-745. [14] Tekeoglu I, Harman H, Sag S, et al.Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis[J]. Cytokine, 2016, 83: 171-175. [15] Saglam M, Koseoglu S, Aral CA, et al.Increased levels of interleukin-33 in gingival crevicular fluids of patients with chronic periodontitis[J]. Odontol, 2017,105(2):184-190. [16] Matsuyama Y, Okazaki H, Tamemoto H, et al.Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis[J]. J Rheumatol, 2010, 37(1): 18-25. [17] Malcolm J, Awang RA, Oliver-Bell J, et al.IL-33 exacerbates periodontal disease through induction of RANKL[J]. J Dent Res, 2015, 94(7): 968-975. [18] Zhang Q, Chen B, Yan F, et al.Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases[J]. Biomed Res Int, 2014, 2014: 284836. [19] Yu P, Hu Y, Liu Z, et al.Local induction of B cell interleukin-10 competency alleviates inflammation and bone loss in ligature-induced experimental periodontitis in mice[J]. Infect Immun, 2016, 85(1): e00645-16. [20] Toker H, Gorgun EP, Korkmaz EM, et al.The effects of IL-10 gene polymorphism on serum, and gingival crevicular fluid levels of IL-6 and IL-10 in chronic periodontitis[J]. J Appl Oral Sci, 2018, 26: e20170232. [21] Guggino G, Giardina A, Ferrante A, et al.The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis[J]. Rheumatol Int, 2015, 35(1): 171-175. [22] Chen S, Chen B, Wen Z, et al.IL-33/ST2-mediated inflammation in macrophages is directly abrogated by IL-10 during rheumatoid arthritis[J]. Oncotarget, 2017, 8(20): 32407-32418. [23] Hernández-Bello J, Oregón-Romero E, Vázquez-Villamar M, et al.Aberrant expression of interleukin-10 in rheumatoid arthritis: Relationship with IL10 haplotypes and autoantibodies[J]. Cytokine, 2017, 95: 88-96. [24] Qu C H, Hou Y, Bi Y F, et al.Diagnostic values of serum IL-10 and IL-17 in rheumatoid arthritis and their correlation with serum 14-3-3eta protein[J]. Eur Rev Med Pharmacol Sci, 2019, 23(5): 1899-1906. [25] 蔡辉, 张群燕. 类风湿关节炎患者外周血血浆中TNF-α、IL-1β及IL-10的表达及临床意义[J].中华中医药学刊, 2017, 35(3): 519-521. |